Glimnew-M2 Tablet PR: A Combination Therapy for Blood Sugar Management

Glimnew-M2 Tablet PR is a once-daily combination medication containing glimepiride (2mg) + metformin (500mg), prescribed to help control blood sugar levels in adults with type 2 diabetes. This convenient tablet formulation allows for consistent dosage management throughout the day.

Glimepiride, a sulfonylurea derivative, stimulates insulin release from pancreatic beta cells to improve glucose uptake by body tissues. Metformin, a first-line oral antidiabetic agent, acts on multiple sites to reduce hepatic glucose production and increase insulin sensitivity.

Benefits of Glimnew-M2:
* Effective in managing blood sugar levels
* Once-daily dosing for ease of use
* Well-tolerated with minimal side effects when taken as directed

This medication is available under prescription and should only be used by individuals diagnosed with type 2 diabetes after consulting a healthcare professional. Always refer to the full prescribing information provided by your doctor or pharmacist before using this medication.

Please note: This description provides general information about Glimnew-M2 Tablet PR. It does not replace professional medical advice. Consult with a qualified healthcare provider for personalized guidance on treatment and care.